Robinhood Seen Benefiting If AI IPOs Boost Retail Trading -- Market Talk
Dow Jones2026/09/09 13:180917 ET - Robinhood could be in for a big boost when AI companies like Anthropic and OpenAI go public, Mizuho analysts say in a note. The analysts highlight how SpaceX's IPO in June, and the elevated tech sentiment afterward, drove a roughly 24% month-over-month increase in equity volumes, and helped the company add about 1 million funded customers in 2Q, its biggest quarterly gain in almost five years. "If the post-SpaceX elevated retail trading environment were to repeat itself, the anticipated AI IPOs in October and in 2027 could meaningfully boost HOOD's trading volumes," the analysts say. They now forecast the company's 4Q equity volumes will increase about 50% year-over-year, up from their prior projection for 16% growth.(kelly.cloonan@wsj.com)
(END) Dow Jones Newswires
September 09, 2026 09:18 ET (13:18 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.
Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.
WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.
Crypto prices
More
